TITLE

Recent Certifications & Approvals

PUB. DATE
June 2013
SOURCE
Nutraceuticals World;Jun2013, Vol. 16 Issue 5, p20
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers news briefs related to food certification and drug approval. All American Pharmaceutical & Natural Foods Corp. (AAP) has been granted orphan drug status by the U.S. Federal Drug Administration (FDA) for one of its patent-pending compounds. Flavorchem Corp. has earned Safe Quality Food (SQF) Level 3, the highest level of certification. Euromed Inc. has gained the stature of being a Good Manufacturing Practices (GMP) facility as registered by NSF International.
ACCESSION #
88086378

 

Related Articles

  • Recent Certifications & Approvals.  // Nutraceuticals World;Mar2012, Vol. 15 Issue 2, p24 

    The article offers news briefs related to drug certifications and approvals in the U.S. in 2012. Robinson Pharma Inc. (RPI) has received certification from NSF International for its dietary supplement facilities. BioExx Specialty Proteins Ltd.'s conclusion about the Generally Recognized As Safe...

  • Science and compliance.  // Food & Drink Technology;Feb2013, Vol. 12 Issue 5, p27 

    The article discusses the requirement of H1 or HT1 certification of the oil as a food grade thermal fluid by the U.S. Food and Drug Administration (FDA) and the non-profit organization NSF International under the food regulations, while using oil-based heat transfer in food applications.

  • News Briefs.  // American Journal of Health-System Pharmacy;9/15/2010, Vol. 67 Issue 18, p1499 

    The article reports that the U.S. Food and Drug Administration (FDA) has approved a new formulation of docetaxel and a needleless intravenous (i.v.) connector with chlorhexidine and silver and zero-fluid displacement.

  • Slew of approvables.  // Drug Topics;11/17/2003, Vol. 147 Issue 22, p27 

    Lists several approval drugs by the U.S. Food and Drug Administration. Ranexa to treat chronic angina; Insulin determir, a long-acting form of the diabetes drug; Fortament, an extended-release product to lower blood glucose.

  • FDA actions in brief.  // Formulary;Feb2010, Vol. 45 Issue 2, p42 

    The article discusses news briefs about drugs approved by the U.S. Food and Drug Administration (FDA). The drugs include dalfampridine extended release tablets, tocilzumab and morphine sulfate oral solution.

  • Pipeline preview.  // Formulary;Apr2010, Vol. 45 Issue 4, p113 

    The article offers U.S. Food & Drug Administration (FDA) drug approval news briefs. Miglustat has been approved for the treatment of Niemann-Pick type C disease, pirfenidone has been recommended for approval to improve lung function and pixantrone has been recommended not to be approved.

  • FDA actions in brief.  // Formulary;Apr2010, Vol. 45 Issue 4, p114 

    The article presents a list of drugs approved by the U.S. Food & Drug Administration (FDA) including doxepin for the treatment of insomnia, adapalene lotion for the treatment of acne and somatropin injection for the treatment of growth hormone disorders.

  • New molecular entities/biologics.  // Formulary;Feb2003, Vol. 38 Issue 2, p78 

    Reports on drugs approved by the U.S. Food and Drug Administration as of February 2003. Extraneal; Humira.

  • FDA Drug Approvals.  // Formulary;Jul2003, Vol. 38 Issue 7, p392 

    Reports on the U.S. Food and Drug Administration's approval of various drugs, as of July 2003. Boniva; Xolair; FluMist.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics